Author

Haiyun Fan 1

1 Pfizer Inc,Collegeville,United States

Item-level improvements in inflammatory bowel disease questionnaire scores in patients with ulcerative colitis treated with tofacitinib induction therapy

Marla C. Dubinsky, Marco DiBonaventura, Haiyun Fan, Andrew G. Bushmakin, Joseph C. Cappelleri, Eric Maller, Andrew J. Thorpe, Leonardo Salese, Julian Panés

Laboratory parameters related to monitoring in patients with ulcerative colitis treated with tofacitinib for up to 3 years in the OCTAVE open-label, long-term extension study

Gil Y. Melmed, Shannon Chang, nicole kulisek, Haiyun Fan, Nervin Lawendy, Eric Maller, Arif Soonasra, Peter Irving

Incidence of venous thromboembolic events in patients with ulcerative colitis treated with tofacitinib in the ulcerative colitis clinical development programme

William Sandborn, Julian Panés, Bruce E. Sands, Walter Reinisch, Chinyu Su, Nervin Lawendy, Nana Koram, Haiyun Fan, Thomas V Jones, Irene Modesto, Daniel Quirk, Silvio Danese

Predictors of delayed response to tofacitinib: results of the octave open study for delayed responders

Miguel Regueiro, Jami A. Kinnucan, Ryan Ungaro, Daniel Quirk, Chinyu Su, Nervin Lawendy, Haiyun Fan, Deborah.A Woodworth, Markus F. Neurath

Item 1 - 4 / 4
1